Morbidity assessment in urinary schistosomiasis infection through ultrasonography and measurement of eosinophil cationic protein (ECP) in urine

Citation
Pdc. Leutscher et al., Morbidity assessment in urinary schistosomiasis infection through ultrasonography and measurement of eosinophil cationic protein (ECP) in urine, TR MED I H, 5(2), 2000, pp. 88-93
Citations number
19
Categorie Soggetti
Envirnomentale Medicine & Public Health
Journal title
TROPICAL MEDICINE & INTERNATIONAL HEALTH
ISSN journal
13602276 → ACNP
Volume
5
Issue
2
Year of publication
2000
Pages
88 - 93
Database
ISI
SICI code
1360-2276(200002)5:2<88:MAIUSI>2.0.ZU;2-3
Abstract
In a Schistosoma haematobium-endemic village in western Madagascar we evalu ated ultrasonography and Eosinophil Cationic Protein (ECP) in urine as mean s to detect the associated urinary tract pathology 192 individuals were mat ched according to age and sex, and grouped intro infected persons with blad der and, if present, kidney pathology (n = 96); infected persons without pa thology (n = 48) and noninfected persons without pathology (n = 48). The me dian urinary egg count was significantly higher in individuals with ultraso nographically detectable urinary tract pathology (115 eggs/10 ml urine) tha n in infected persons without (45 eggs/10 ml of urine). At 136 ng/ml, the m edian ECP level was significantly higher in the 144 infected individuals th an in the 48 noninfected persons (0.35 ng/ml). Egg excretion correlated pos itively with ECP level. The median ECP level was significantly higher in th e group with ultrasonographically detectable urinary trace pathology than i n the group without (183 ng/ml vs. 67 ng/ml). The results suggest that mino r degrees of pathology, particularly at an early stage of infection with S. haematobium, might be overlooked by ultrasonography despite the presence o f marked inflammation, as indicated by markedly increased urinary ECP level s in infected individuals without ultrasonographically detectable urinary t race pathology. ECP may therefore provide important information on the evol ution of S. haematobium-associated urinary tract morbidity.